Medical information Clinical review pending

Genetic Testing

MEGF10 Gene Myopathy Areflexia Respiratory Distress and Dysphagia Early-Onset Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to detect mutations in the MEGF10 gene, associated with early-onset myopathy, areflexia, respiratory distress, and dysphagia.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: No special preparation is typically required for this blood test. However, confirm with the laboratory for any specific instructions.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the MEGF10 Gene Myopathy Areflexia Respiratory Distress and Dysphagia Early-Onset Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Presence of muscle weakness (myopathy)
✓Absence of reflexes (areflexia)
✓Respiratory distress
✓Difficulty swallowing (dysphagia)
✓Family history of neurological disorders with similar symptoms
✓Early-onset neurological symptoms

In plain language

What this test helps you understand

This test helps identify mutations in the MEGF10 gene, which can confirm a diagnosis of MEGF10-related myopathy. This information can guide clinical management, genetic counseling, and family planning.

The MEGF10 Gene Myopathy Areflexia Respiratory Distress and Dysphagia Early-Onset NGS Genetic DNA Test is an advanced diagnostic tool used to identify genetic disorders linked to neurological conditions. This test utilizes Next-Generation Sequencing (NGS) technology to provide detailed information about the MEGF10 gene. Mutations in this gene can cause conditions characterized by muscle weakness (myopathy), absence of reflexes (areflexia), breathing difficulties (respiratory distress), and trouble swallowing (dysphagia). Early detection of these genetic changes is important for managing and treating affected individuals effectively. This test is particularly relevant for individuals presenting with symptoms suggestive of these conditions or those with a family history of similar neurological disorders. Consulting with a healthcare provider, such as a neurologist or genetic counselor, is recommended to determine if this test is appropriate.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo special preparation is typically required for this blood test. However, confirm with the laboratory for any specific instructions.

SampleBlood sample (usually collected in an EDTA tube). Confirm specific requirements with the laboratory before booking.

MethodologyNext-Generation Sequencing (NGS) of the MEGF10 gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects mutations within the MEGF10 gene. It may not detect mutations in other genes that could cause similar symptoms. Results should be interpreted alongside clinical findings. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

This test looks for specific genetic changes (mutations) in the MEGF10 gene, which are associated with certain neurological conditions like muscle weakness, breathing problems, and swallowing difficulties.

Individuals experiencing symptoms like muscle weakness, lack of reflexes, respiratory distress, or difficulty swallowing, especially if symptoms started early in life or if there is a family history of similar conditions, may be candidates for this test.

A healthcare provider or genetic counselor will interpret the test results in relation to your symptoms and medical history to provide a diagnosis or further guidance.

Yes, this test typically requires a blood sample. Please confirm the exact specimen requirements with the laboratory.

Turnaround time can vary. Please contact the laboratory directly for the most current information.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp